Drug Trial Radar · NCT06842199
Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis
Last checked: Nov 19, 2026Latest source record: Feb 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
383
Planned (sponsor's estimate)
Start
Mar 20, 2025
Primary completion
May 2026
Study completion Feb 2027
Sponsor
- Lead sponsor
- Beijing InnoCare Pharma Tech Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Feb 24, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, randomized, double-blind, placebo-controlled Phase III clinical study to evaluate the efficacy, safety, PK characteristics of ICP-488 in Chinese adults with moderate to severe plaque psoriasis.
Conditions
- Plaque Psoriasis Patients
Interventions
ICP-488 TabletsDrug
Eligible patients will receive ICP-488 orally as per the protocol
ICP-488 PlaceboDrug
Eligible patients will receive ICP-488 Placebo orally as per the protocol
Primary outcomes
What the sponsor says the trial is designed to measure.
- The proportion of subjects who achieve a score of clear (0) or almost clear (1) with an improvement of at least 2 points from baseline on the static Physician's Global Assessment (sPGA) at week 16Time frame: week 16
- Percentage of subjects who achieved a PASI 75 response (a reduction of minimum 75% from baseline in PASI score) at Week 16Time frame: Week 16
Locations
46 sites in 1 country. Site status is shown where the registry gives one.
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China · Completed
The Second Affiliated Hospital of Wannan Medical College
Wuhu, Anhui, China · Completed
Beijing Chao-Yang Hospital,Capital Medical University
Beijing, Beijing Municipality, China · Completed
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China · Completed
Peking University Third Hospital
Beijing, Beijing Municipality, China · Completed
Beijing Tongren Hospital,CMU
Beijing, Beijing Municipality, China · Completed
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China · Completed
Chongqing Traditional Chinese Medicine Hospital
Chongqing, Chongqing Municipality, China · Completed
Fujian Medical University Union Hospital
Fuzhou, Fujian, China · Completed
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China · Completed
Dermatology Hospital of Southern Medical University
Guangzhou, Guangdong, China · Completed
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China · Completed
Liuzhou People's Hospital
Liuzhou, Guangxi, China · Completed
The Affiliated Hospital of Guizhou Medical University
Guiyang, Guizhou, China · Completed
Affiliated Hospital of Chengde Medical University
Chengde, Hebei, China · Completed
The Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, China · Completed
The 2nd Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China · Completed
The Second Affiliated Hospital of Henan University of Science and technology
Luoyang, Henan, China · Completed
Nanyang Central Hospital
Nanyang, Henan, China · Completed
Sanmenxia Central Hospital
Sanmenxia, Henan, China · Completed
Henan Provincial People's Hospital
Zhengzhou, Henan, China · Completed
Jingzhou Central Hospital
Jingzhou, Hubei, China · Completed
Wuhan Hospital Of Traditional Chinese and Western Medicine (Wuhan No.1 Hospital)
Wuhan, Hubei, China · Completed
Xiangya Hospital of Central South University
Changsha, Hunan, China · Completed
The Second Xiangya Hospital of Central South
Changsha, Hunan, China · Completed
The First People's Hospital of Changzhou
Changzhou, Jiangsu, China · Completed
The First People's Hospital of Lianyungang
Lianyungang, Jiangsu, China · Completed
Hospital for skin diseases,Institute of dermatology chinese academy of medical sciences,peking union medical college
Nanjing, Jiangsu, China · Completed
First Affiliated Hospital of Gannan Medical University
Ganzhou, Jiangxi, China · Completed
Dermatology Hospital of Jiangxi Province
Nanchang, Jiangxi, China · Completed
The First Hospital of Jilin University
Changchun, Jilin, China · Completed
Northeast International Hospital
Shenyang, Liaoning, China · Completed
Qilu Hospital of Shandong University
Jinan, Shandong, China · Completed
Huashan Hospital, Fudan University
Shanghai, Shanghai Municipality, China · Completed
Shanghai Skin Disease Hospital skin Disease of tongji University
Shanghai, Shanghai Municipality, China · Completed
Taiyuan Central Hospital
Taiyuan, Shanxi, China · Completed
The First Affiliated Hospital of Xi'an Jiaotong University
Xi’an, Shanxi, China · Recruiting
The Second Affiliated Hospital of Xi'an Jiaotong University
Xi’an, Shanxi, China · Completed
Chengdu Second People's Hospital
Chengdu, Sichuan, China · Completed
Sichuan Provincial People's Hospital
Chengdu, Sichuan, China · Completed
Showing 40 of 46 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.